News Agency
Men's Weekly

Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development

  • Written by PR Newswire

TAIPEI, Feb. 1, 2024 /PRNewswire/ -- Anbogen Therapeutics, a clinical-stage biotechnology company specializing in groundbreaking cancer drug development, today announced the successful completion of its Series A funding round. The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital,...

Read more: Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development

Gender-Inclusive Lash Treatments: Breaking Beauty Norms

Beauty is no longer defined by traditional gender standards, and the lash industry is evolving to reflect that.  In 2026, more clients of all genders are seeking lash lifts, tints, and extensions that enhance their natural features while respecting individual style... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion